GCP
LVGO

GSA Capital Partners’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

GSA Capital Partners’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,411
Closed -$712K – 1756
2019
Q4 		$712K Buy
+28,411
New +$679K 0.08% 413

Other funds holding LVGO

KXA
KPCB XVI Associates Menlo Park, California $225M AUM 26.26% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
SV
Sapphire Ventures Austin, Texas $99.4M AUM 23.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's LVGO Position: Q1 2020 in Review

GSA Capital Partners sold out of Livongo Health, Inc. Common Stock (LVGO) in Q1 2020, closing a stake of 28,411 shares — an estimated $712K sold.

GSA Capital Partners first reported a position in LVGO in Q4 2019 and held it in 1 quarter. The position peaked at $712K in Q4 2019. 145 funds tracked by Wall St. Rank hold LVGO as of Q1 2020.

  • GSA Capital Partners reported no remaining Livongo Health, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • GSA Capital Partners sold 28,411 Livongo Health, Inc. Common Stock shares in Q1 2020, an estimated $712K.
  • GSA Capital Partners first reported a position in Livongo Health, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • GSA Capital Partners's Livongo Health, Inc. Common Stock position peaked at $712K in Q4 2019.
  • 145 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q1 2020.

Based on GSA Capital Partners's 13F filing for Q1 2020, filed 12 May 2020.